GRI Bio Inc. (GRI)
NASDAQ: GRI
· Real-Time Price · USD
1.40
-0.04 (-2.78%)
At close: Aug 15, 2025, 3:59 PM
1.44
2.86%
After-hours: Aug 15, 2025, 07:46 PM EDT
GRI Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1K | n/a | n/a | n/a | n/a | n/a | 1K | 2K | n/a | n/a | 169K | 18K | 19K | 18K | 19K | 10K | 28K |
Gross Profit | -1K | n/a | n/a | n/a | n/a | n/a | -1K | -2K | n/a | n/a | -169K | -18K | -19K | -18K | -19K | -10K | -28K |
Operating Income | -3.05M | -1.95M | -2.13M | -2.26M | -1.9M | -2.03M | -2.44M | -5.93M | -2.35M | -1.39M | -1.4M | -1.51M | -2.63M | -3.09M | -1.25M | -2.31M | -2.6M |
Interest Income | 5K | 6K | 7K | 6K | 6K | 7K | 6K | n/a | 16K | 26K | 2K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.05M | -1.95M | -2.12M | -2.25M | -1.89M | -2M | -2.14M | -6.75M | -2.4M | -1.58M | -1.03M | -1.77M | -2.63M | -3.1M | -1.26M | -2.31M | -2.64M |
Net Income | -3.05M | -1.95M | -2.12M | -2.25M | -1.89M | -2M | -2.14M | -6.75M | -2.4M | -1.58M | -1.03M | -1.77M | -2.63M | -3.1M | -1.26M | -2.31M | -2.64M |
Selling & General & Admin | 1.41M | 1.13M | 1M | 1.38M | 962K | 980K | 1.25M | 5.05M | 2.47M | 1.74M | 1.25M | 1.21M | 1.34M | 1.08M | 1.02M | 1.1M | 802K |
Research & Development | 1.64M | 828K | 1.13M | 877K | 933K | 1.05M | 1.19M | 880K | -124K | -359K | -18K | 278K | 1.27M | 2M | 215K | 1.2M | 1.77M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.05M | 1.95M | 2.13M | 2.26M | 1.9M | 2.03M | 2.44M | 5.93M | 2.35M | 1.39M | 1.24M | 1.49M | 2.62M | 3.08M | 1.23M | 2.3M | 2.57M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 934K | n/a | n/a | n/a | 1K | 1K | 2K | 4K | 2K | 8K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.05M | 1.95M | 2.13M | 2.26M | 1.9M | 2.03M | -2.44M | -5.93M | -2.35M | -1.39M | -1.4M | -1.51M | -2.63M | -3.09M | -1.25M | -2.31M | -2.6M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 525.45K | 183.28K | 185.93K | 457.73K | 317.49K | 49.67K | 45.32K | 26.57K | 49.39K | 49.39K | 44.34K | 31.81K | 24.96K | 24.96K | 24.96K | 24.96K | 24.96K |
Shares Outstanding (Diluted) | 525.45K | 183.28K | 185.93K | 457.73K | 317.49K | 49.67K | 45.32K | 26.57K | 49.39K | 49.39K | 44.34K | 31.81K | 24.96K | 24.96K | 24.96K | 24.96K | 24.96K |
EPS (Basic) | -5.8 | 140.81 | -11.42 | -83.56 | -101.04 | -685.86 | -801.55 | -4.32K | -8.25K | -5.45K | -3.96K | -9.48K | -17.95K | -21.09K | -8.56K | -15.75K | -17.97K |
EPS (Diluted) | -5.8 | 140.81 | -11.42 | -83.56 | -101.04 | -685.86 | -801.55 | -4.32K | -8.25K | -5.45K | -3.96K | -9.48K | -17.95K | -21.09K | -8.56K | -15.75K | -17.97K |
EBITDA | -3.05M | -1.95M | -2.13M | -2.26M | -1.89M | -1.59M | -2.14M | -5.81M | -2.4M | -1.58M | -864K | -1.75M | -2.62M | -3.14M | -1.23M | -2.3M | -2.6M |
EBIT | -3.05M | -1.95M | -2.13M | -2.26M | -1.9M | -1.59M | -2.14M | -5.81M | -2.4M | -1.58M | -1.03M | -1.77M | -2.63M | -3.15M | -1.25M | -2.31M | -2.63M |
Depreciation & Amortization | 1K | 1K | 1K | 1K | 1K | 15K | 1K | 2K | n/a | n/a | 169K | 18K | 19K | 18K | 19K | 10K | 28K |